when do you stop feeling hungry on semaglutide How Long Does Take to Suppress Appetite? Semaglutide Side Effects Week by

Already in effect (January 1, 2026): Standard PA decisions within 7 calendar days (down from 14) Urgent PA decisions within 72 hours Specific denial reasons required on every denial (not just not medically necessary) Applies to Medicare Advantage, Medicaid managed care, CHIP, and ACA Marketplace plans Coming March 31, 2026: Payers must publicly report PA metrics for calendar year 2025: approval/denial rates, average decision times, and appeals outcomes Providers will be able to compare payer performance for the first time Coming January 1, 2027: FHIR-based Prior Authorization APIs required providers check PA requirements, submit requests, and receive decisions electronically through their EHR Expected to reduce average PA processing time from days to minutes for standard requests Medicare WISeR Model (live in AZ and WA): The Wasteful and Inappropriate Services Reduction pilot launched January 2026 in six states including Arizona and Washington

The second tested Zepbound in adults with the same conditions, but those participants were on and planned on continuing PAP therapy

The World Anti-Doping Agency (WADA) added BPC-157 to its S0 prohibited list (Non-Approved Substances) in 2022

Wegovy is an injectable weight loss medication that belongs to a group of medicines called GLP-1 receptor agonists (typically referred to as GLP-1s)

Significant & Proven Fat Loss : Clinically optimized to help patients drop a substantial percentage of body weight, specifically targeting visceral fat